Idorsia Pharmaceuticals UK Ltd.: New research reveals chronic insomnia disorder costs UK economy up to £34billion per year
First of its kind research indicates that if chronic insomnia disorder (CID) was treated effectively and comprehensively across the working age population, it could increase the GDP in the UK